BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Polidoro MA, Mikulak J, Cazzetta V, Lleo A, Mavilio D, Torzilli G, Donadon M. Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells. World J Gastroenterol 2020; 26(33): 4900-4918 [PMID: 32952338 DOI: 10.3748/wjg.v26.i33.4900]
URL: https://www.wjgnet.com/1948-5204/full/v26/i33/4900.htm
Number Citing Articles
1
Xiulin Xiao, Lin Zhou, Long Zhang, Zhiyuan Xu, Qixin Dai, Xiaohong Deng, Weiguo Li. Short-Term and Long-Term Curative Effect of Partial Hepatectomy on Ruptured Hemorrhage of Primary Liver Cancer after TAEEmergency Medicine International 2022; 2022: 1 doi: 10.1155/2022/2484418
2
Massimiliano Cadamuro, Rocio I.R. Macias, Alastair J. Strain, Mario Strazzabosco, Paolo Simioni, Jose J.G. Marin, Luca Fabris. Unmet needs in basic and translational research in CholangiocarcinomaLiver Cancer International 2022; 3(1): 5 doi: 10.1002/lci2.39
3
Neda Minaei, Roya Ramezankhani, Atena Tamimi, Abbas Piryaei, Ali Zarrabi, Amir Reza Aref, Ebrahim Mostafavi, Massoud Vosough. Immunotherapeutic approaches in Hepatocellular carcinoma: Building blocks of hope in near futureEuropean Journal of Cell Biology 2023; 102(1): 151284 doi: 10.1016/j.ejcb.2022.151284
4
Chengwen He, Qin Wei, Jun Zhu, Qin Qin, Huaizhou Wang, Shanrong Liu. Clinical value of assessing serum levels of inflammatory cytokines in the early diagnosis of patients with primary liver carcinoma: a retrospective observational studyJournal of Bio-X Research 2021; 4(1): 29 doi: 10.1097/JBR.0000000000000084
5
Valentina Cazzetta, Sara Franzese, Claudia Carenza, Silvia Della Bella, Joanna Mikulak, Domenico Mavilio. Natural Killer–Dendritic Cell Interactions in Liver Cancer: Implications for ImmunotherapyCancers 2021; 13(9): 2184 doi: 10.3390/cancers13092184
6
Ruyin Chen, Qiong Li, Shuaishuai Xu, Chanqi Ye, Tian Tian, Qi Jiang, Jianzhen Shan, Jian Ruan. Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironmentCancer Cell International 2022; 22(1) doi: 10.1186/s12935-021-02435-4
7
Devaraj Ezhilarasan, Mustapha Najimi. Deciphering the possible reciprocal loop between hepatic stellate cells and cancer cells in the tumor microenvironment of the liverCritical Reviews in Oncology/Hematology 2023; 182: 103902 doi: 10.1016/j.critrevonc.2022.103902
8
Sara Piccinelli, Rizwan Romee, Roman M. Shapiro. The natural killer cell immunotherapy platform: An overview of the landscape of clinical trials in liquid and solid tumorsSeminars in Hematology 2023; 60(1): 42 doi: 10.1053/j.seminhematol.2023.02.002
9
Matteo Donadon, Marcello Di Martino, Paolo Baroffio, Michela Anna Polidoro. Reflections and perspectives on adjuvant treatment in the setting of resected hepatocellular carcinomaHepatoma Research 2024;  doi: 10.20517/2394-5079.2024.14
10
Dashuai Yang, Yu Zhou, Yanbing Zhang, Yang Su, Jie Shen, Bin Yu, Kailiang Zhao, Youming Ding. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq data reveals dynamic changes in tumor-associated neutrophils in the tumor microenvironment of hepatocellular carcinoma and leads to the establishment of a neutrophil-related prognostic modelCancer Immunology, Immunotherapy 2023; 72(12): 4323 doi: 10.1007/s00262-023-03567-4
11
Piyush Gondaliya, Adil Ali Sayyed, Julia Driscoll, Krishna Patel, Tushar Patel. Extracellular vesicle RNA signaling in the liver tumor microenvironmentCancer Letters 2023; 558: 216089 doi: 10.1016/j.canlet.2023.216089
12
Francesca Vita, Irene Olaizola, Francesco Amato, Colin Rae, Sergi Marco, Jesus M. Banales, Chiara Braconi. Heterogeneity of Cholangiocarcinoma Immune BiologyCells 2023; 12(6): 846 doi: 10.3390/cells12060846
13
Pratiksha Tiwari, Krishna Yadav, Ravi Prakash Shukla, Shalini Gautam, Disha Marwaha, Madhu Sharma, Prabhat Ranjan Mishra. Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapyJournal of Controlled Release 2023; 363: 290 doi: 10.1016/j.jconrel.2023.09.016
14
Qijie Zhao, Rawiwan Wongpoomchai, Arpamas Chariyakornkul, Zhangang Xiao, Chalermchai Pilapong. Identification of Gene-Set Signature in Early-Stage Hepatocellular Carcinoma and Relevant Immune CharacteristicsFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.740484
15
Guangsheng Zhao, Mei Bi, Song Liu, Jian Ma, Fang Xu, Ying Liu, Fei Gao, Ying Yu, Jun Zhou, Zhuo Feng, Jianlin Wu. Variation of NK, NKT, CD4+ T, CD8+ T cells, and IL-17A by CalliSpheres® microspheres-transarterial chemoembolization in refractory liver metastases patientsScandinavian Journal of Clinical and Laboratory Investigation 2022; 82(7-8): 549 doi: 10.1080/00365513.2022.2129438
16
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, Craig McFarlane, Lionel Hebbard. Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic dataSeminars in Cancer Biology 2022; 86: 799 doi: 10.1016/j.semcancer.2022.01.005
17
Haipeng Zhu, Xiaojun Liu. Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal MalignanciesFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.666340
18
Adriana G. Quiroz Reyes, Sonia A. Lozano Sepulveda, Natalia Martinez-Acuña, Jose F. Islas, Paulina Delgado Gonzalez, Tania Guadalupe Heredia Torres, Jorge Roacho Perez, Elsa N. Garza Treviño. Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular CarcinomaTechnology in Cancer Research & Treatment 2023; 22: 153303382311636 doi: 10.1177/15330338231163677
19
Yinghui Zhu, Dezhi Shan, Lianyi Guo, Shujia Chen, Xiaofei Li. Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular CarcinomaInternational Journal of General Medicine 2022; : 1919 doi: 10.2147/IJGM.S343350